Journal Title:Advances In Integrative Medicine
The Journal of Advances in Integrative Medicine is renowned for its high standards of scientific publication and rigorous review process. It adopts an international standard double-blind review system to ensure that each manuscript undergoes rigorous review by professional scholars and experts, ensuring the scientific, innovative, and reliable nature of its content. Its publication scope is extensive, covering multiple fields such as traditional Chinese and Western medicine and dietary therapy, joint research between traditional Chinese medicine and Western medicine, the latest developments in precision medicine, and the impact of genomics on disease prevention and treatment. It comprehensively focuses on the full lifecycle management of diseases, including new technologies, methods, and products related to disease occurrence and development, screening and early warning, diagnostic typing, treatment intervention, and prognosis.
In addition, the journal also focuses on the challenges and opportunities in the global health field, as well as the importance of equal access to healthcare for all, and is committed to promoting the development and popularization of integrated medicine on a global scale. Its international editorial team and open access publishing strategy further promote the widespread dissemination and collaborative exchange of academic achievements.
《综合医学的进展杂志》以高标准的科学发表和严格的审稿流程著称,采用国际标准的双盲评审制度,确保每篇稿件都经过专业学者和专家的严格审核,以保证内容的科学性、创新性和可靠性。其发表范围广泛,涵盖中西药与膳食疗法、中医与西医联合研究、精准医学的最新发展、基因组学对疾病预防和治疗的影响等多个领域,全面关注疾病的全生命周期管理,包括疾病的发生发展、筛查预警、诊断分型、治疗干预及转归预后等方面的新技术、新方法和新产品。
此外,该期刊还关注全球卫生领域的挑战和机遇,以及人人平等享有医疗保健的重要性,致力于推动综合医学在全球范围内的发展与普及。其国际化的编委团队和开放获取的出版策略,进一步促进了学术成果的广泛传播与合作交流。
Advances In Integrative Medicine由Elsevier出版商出版,收稿方向涵盖INTEGRATIVE & COMPLEMENTARY MEDICINE全领域,平均审稿速度 15 Weeks ,影响因子指数1.2,该期刊近期没有被列入国际期刊预警名单,广大学者值得一试。
按JIF指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
学科:INTEGRATIVE & COMPLEMENTARY MEDICINE | ESCI | Q3 | 28 / 43 |
36% |
按JCI指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
学科:INTEGRATIVE & COMPLEMENTARY MEDICINE | ESCI | Q3 | 30 / 43 |
31.4% |
名词解释:
WOS即Web of Science,是全球获取学术信息的重要数据库,Web of Science包括自然科学、社会科学、艺术与人文领域的信息,来自全世界近9,000种最负盛名的高影响力研究期刊及12,000多种学术会议多学科内容。给期刊分区时会按照某一个学科领域划分,根据这一学科所有按照影响因子数值降序排名,然后平均分成4等份,期刊影响因子值高的就会在高分区中,最后的划分结果分别是Q1,Q2,Q3,Q4,Q1代表质量最高。
CiteScore | SJR | SNIP | CiteScore排名 | ||||||||
3.2 | 0.329 | 0.493 |
|
名词解释:
CiteScore:衡量期刊所发表文献的平均受引用次数。
SJR:SCImago 期刊等级衡量经过加权后的期刊受引用次数。引用次数的加权值由施引期刊的学科领域和声望 (SJR) 决定。
SNIP:每篇文章中来源出版物的标准化影响将实际受引用情况对照期刊所属学科领域中预期的受引用情况进行衡量。
是否OA开放访问: | h-index: | 年文章数: |
开放 | -- | 19 |
Gold OA文章占比: | 2021-2022最新影响因子(数据来源于搜索引擎): | 开源占比(OA被引用占比): |
4.17% | 1.2 | |
研究类文章占比:文章 ÷(文章 + 综述) | 期刊收录: | 中科院《国际期刊预警名单(试行)》名单: |
100.00% | SCIE | 否 |
历年IF值(影响因子):
历年引文指标和发文量:
历年自引数据:
若用户需要出版服务,请联系出版商。